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Tyrosinase induction in murine malignant melanoeytes by gMSH is well known, but its molecular basis has not been characterized. Treatment 
of BI6 melanoma cells with theophylline or rrMSH mediates a larger induction of tyrosine hydroxylase than of dopa oxidase activity in total cell 
extracts, and in the melanosomal nd microsomal fractions. No evidence for the modulation of a tyrosinase effector was found. SDS-PAGE and 
slY~ific activity stain demonstrated two forms of tyro.,i~ase, with different degrees of induction by theophylline. These results agree with the recent 
proposal that two tyrosinases, encoded by different genes, are present in murine melanoeytes. 
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I, INTRODUCTION 
It has been known for a long time that ~MSH binding 
to specific receptors in mammalian melanocytes triggers 
a series of cAMP-mediated events, leading to a large 
increase in tyrosinase activity [1], the enzyme control- 
ling the rate of melanin synthesis. However, the molec- 
ular mechanisms underlying tyrosinase induction are 
far from clear. It has been suggested that the effect of 
czMSH is not mediated by a change in the phosphoryla- 
tion state of tyrosinase or in other post-translational 
modifications [2,3]. However, there is no agreement as 
to whether the increase in tyrosinase activity is mainly 
a function of enzyme abundance [3,4], or reflects both 
an increased amount of tyrosinase and an activation of 
previously existing molecules [5], or even the activation 
of an inactive enzyme pool with little, if any, effect on 
the rate of enzyme synthesis [6]. As far as the activation 
of pre-existing tyrosinase molecules is concerned, both 
the cAMP-mediated removal of an inhibitor [7] or syn- 
thesis of an activator [5] have been postulated, although 
no clear-cut evidence has ever been put forward. 
We present evidence suggesting that treatments in- 
creasing the cAMP content of B16 mouse melanoma 
Abbreviations: L-dOpe, L-3,4-dihydroxyphenylalanine; EDTA, cthyle- 
nediaminetetraacetie acid; ctMSH, ot-melanoeyte .~.'.imulating 
hormone; PAGE, polyacrylamide g l eleetrophoresis; PMSF, phen- 
ylmethylsulfonyl fluoride; SDS. sodium dodecyl sulfate. 
Correspondence address: J.C. Gareia-Borrdn, Departamento de 
Bioquimiea y Biologla molecular, Faeultad e Medicina, Univ.~rsidad 
de Mureia, 30100 Espinardo, Marcia, Spain. Fax: (34) (68) 834307. 
cells in culture trigger the preferential expression of a 
tyrosinase isoenzyme different from the majority form 
found in untreated cells. Both forms differ in their elec- 
trophoretie mobility in non-reducing SDS-PAGE and 
in their catalytic properties. The isoenzyme preferen- 
tially induced by melanogenic agents displays a larger 
ratio of tyrosine hydroxylase to dopa oxidase activity, 
and would therefore mainly affect he first, rate limiting, 
step of the pathway. This finding conveniently accounts 
for most of the apparently controversial data in the 
literature. 
2. MATERIALS AND METHODS 
2,1. Cell culture attd treatment withmelanogenic effectors 
BI6-F10 mouse melanoma cells were originally a kind gift of Dr. 
V. Hearing and have been maintained as described [8], BI6 mela- 
nocytes were culttared either on 96-well plates or in 75 cm: flasks from 
Nunc (Denmark). When using 9f-well plates, cells were seeded at a 
density of 5,000 ceils per well in 200/.tl of medium. After 24 h, serial 
dilutions of the melanogenie effectors were added in $0/,tl of medium, 
and the plate was further incubated for 48 h. Each concentration was 
assayed in six independent wells the contents of which were pooled by 
pairs before measurements so as to assay enzymatic activities in trip- 
licate. To obtain higher amounts of cells for subcgllular fraetionation 
experiments. 5 • I0 S cells were sceclcd in 75 am" flasks, incubated for 
24 h and then a volume of medium containing the desired con~ntra- 
lion of the melanogenic agent was added. 
2.2. Subcellular fractionatton 
Cells were harvested by trypsin treatment and washed twice by 
centrifugation i  homogenization buffer (HB, 10 mM phosphate pH 
6.8, 0.25 M sucrose, 0.1 mM EDTA, 0.1 mM PMSF). The washed cells 
were suspended in HB at about I07 c.ll~'ml and disrupt,-d M a loose- 
fitting, manual, glass-teflon homogenizer, at4"C. A post-nuclear su- 
pernatant was obtained by centrifugation at 700 x g, and further 
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ffactionated by differential centrifugation at 11,000 × g, 30 rain. yield- 
ing a melanosome-rich pellet. This was followed by centrifu~ation at 
105,000 × g for 60 rain to yield the microsomal fraction. 
Before activity measurements, the pellets were solubilized in lb mM 
phosphate pH 6.8 containing 1% Brij 35 and eentrifugation at 105,000 
x g, 60 min, using 200 ~1 of solubilization buffer per 107 cells. 
2,3, Activity meaa'uremettts 
The formation of melanin by cells in culture was dircmly determined 
in 96.well plates, as described by Sicgrist and Eberl¢ [9], Tyrosine 
hydroxylase activity was measured by the method of Pomerantz [10] 
modified as described elsewhere [11], Dt~pa e,~idase activity was deter- 
mined by following spectrophotometrieally the Formation ol" do- 
pachrome from L-dopa, One unit of tyrosine hydroxylase activity was 
defined as the amount of enzyme that hydroxylates 1/~mol h-Tyr/min, 
whereas one unit of dopa oxidase was defined as the amount of 
tyrosinase that catalyzes the oxidation of 1 Mmol L-dopa/min, as re- 
ported previously [11]. 
2.4. Other procedures 
Non-reducing SDS.PAGE was perfomaed according to Laemmli 
[12], but in the absence of~'.mercaptoethanol d without any heating 
in order to preserve nzymatic activities, Before electrophoresis, sam. 
ples were mixed in a 2:1 (v/v) ratio with sample buffer (0,18 M Tris- 
HCI, pH 6,8. 15% glycerol, 9% SDS and 0,075% Bromophenol b ue) 
and incubated at room temperature for 30 min. Specific tyrosinase 
activity stain was performed by incubation of the gels at 37°C for 2 
h in I0 mM phosphate buffer pH 6,8 containing 1,5 mM L-dopa 
supplemented with 0,5 l.zCi/ml of L-[3-C14]dopa from New England 
Nuctear. The gels were incubated in Amplify enhancer from Amer- 
sham for 30 rain, dried, photographed and further analyzed by fluoro- 
graphy using Kodak X-OMAT AR film. Protein was determined as 
described by Hartre¢ [13], 
3, RESULTS AND DISCUSSION 
Fig. 1 shows the dose-response curves obtained for 
unfractionated B15 cells grown in 96-well plates and 
treated for 48 h with theophylline. The cells responded 
with a large increase in melanin synthesis and, as shown 
in Fig. l, a dramatic and dose-dependent stimulation of 
the tyrosine hydroxylase activity (approximately 30- 
fold increase over the control). The dopa oxida~ activ- 
ity displayed a considerably smaller activation, of about 
12-fold the control values. A similar situation was found 
for gMSH and for the more stable and more potent 
analogue [NLeu+,D-PheT]-~MSH (Table I). in principle, 
this result could be explained by the modulation of a 
specific effcctor with different effects on the tyrosine 
hydroxylase and dopa oxidase activities. Since melanin 
synthesis i confined to the melanosomes, experiments 
were performed to investigate he presence of such an 
effector in the melanosomal fraction ofcontrol and the- 
ophylline-treated cells. However, as shown in Table II, 
no evidence pointing to the existence of such an effector 
was found in experiments where the activity of mixtures 
of control and treated melanosomal extracts was meas- 
ured. Moreover, the addition of SDS to reaction mix- 
tures did not have any effect on the activity of either 
control or treated samples, or their combinations (Table 
II). It is worth noting that the number of/.tU in control 
and treated samples does not reflect he actual induction 
of tyrosine hydroxylase activity, since the number of 
cells was lower after theophylline treatment as com- 
pared to the controls, and the volume of theophylline- 
treated extracts in the assay medium was lower than the 
one of control extracts. In addition, the tyrosine hy- 
droxylation reaction rate of control and treated extracts 
varied linearly with the amount of extract used in the 
assays (not shown) as expected for an enzymatic prepa- 
ration devoid of effectors [14]. 
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Fig. i. Dose-response curves of the Lyroslnas= activities of BI6 melanoma cells treated wi:h th=oph:,'lline. The treatments were carried ollt as 
described in Materials and Methods and in Table I. Each point is the mean of thro~ independent ¢~l~riments. Error bars are shown only when 
they were larger than the symbol. (I) lyrosine hydroxylase activity, and (o) dopa oxidase activity, expressed inmU/mg protein; (&) ratio of tyrosine 
hydroxylase todopa oxidase activity, expressed in#U/mU. 
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Fig, 2. Activity stain of SDS-PAGE non-reducing gels of the miero- 
somal and melanosomal fractions ofeontrol and theophylline-treated 
cells, Control and cells treated with theophylline (1 raM) for different 
times were submitted to subcellular fraetionation and their melano- 
somal and mierosomal fractions olubilized. A volume of the solubil- 
ized extracts corresponding to 3,10 s cells was eleetrophoresed and the 
gel stained for activity with radioactive L-dope and analyzed by fluoro- 
graphy, The time of exposure was 5 days. Lanes 1 to 4, microsomal 
entraets ofcontrol cells (I) and cells treated lbr 16, 24 and 48 h (2 to 
4); lanes 5 to 8, melanosomal extracts control cells (5) and cells treated 
for 16, 24 and 48 h (6 to 8); lane 9, reduetivcly methylated BSA, 
Another possible explanation for the relative change 
in the ratio of tyrosine hydroxylation to dopa oxidation 
was the cAMP-mediated induction of a different isoen- 
zyme with distinct kinetic parameters for both activities. 
Such a possibility will be consistent with the proven 
necessity of continued transcription and translation for 
the apparent activation process [5] and with the recently 
Table I 
Effect of different melanogenie a,gents on the dope ozidase al~d tyro- 
sine hydroxylase activities of BI6 mouse melanoma cells 
Treatment T~,rosine hydrox. 
ylase 
~U/mg protein) 
Dope o×ida:;e Ratio 
(mU/mg protein) ~U/mU)  
Control 11,4 ± 2.6 1,6 _+ 0,3 7.1 
Theophylline 327,1 + 25,9 (28.7) 20,2 + 2,3 (12.5) 16.2 
~MSH 65.0 _'4:. 3.7 (5.7) 4.8 _+ 0.3 (3.0) 13.5 
NLeu'~,DPhe "J- 117,2 ± 11,3 (10,3) 6,1 +_ 0.5 (3,8) 19.2 
aMSH 
All ~rcattnents were carried out for 48 h with cells grown in 96-well 
culture plates. Theophylline was 1 raM, whereas rnMSH and its ana- 
logue were I0 -r M. Culture media were removed and the cells were 
solubilizgd by addition of 1% Brij 35 in 10 mM phosphate buffer, pH 
6,8, using 100/.tl of buffer/well, After 1 h incubation at room temper- 
ature, the solubilized .samples were centrifuged at 105,000 × g, for 1 
h. and measurements were carried out on the supernatant fractions, 
The stiraulation achieved is shnwn in brackets. The results are the 
mean +_ S.E,M, for two independent experiments, each one carried out 
in triplicate. 
reported existence of more than one tyrosinase in mam- 
malian melanoeytes, the b and c proteins [15,16]. To 
check this possibility, two approaches were followed. 
First, the activation of both tyrosinase activities was 
analyzed in the microsomes (containing newly synthe- 
sized enzyme 'en route' to the melanosomes) and the 
melanosomal fi'action, As shown in Table III, the newly 
synthesized microsomal tyrosinase already displayed a
ratio of tyrosine hydro:~ylation to dopa oxidation 
higher in theophylline treated cells than for control 
cells. More conclusively, a sensitive activity stain of 
$DS-PAGE gels based on the fluorographic detection 
of radioactive melanin (to be published) showed a dif- 
ferent pattern of activity bands in control and theophyl- 
line-treated cells (Fig, 2). In control cells, an activity 
baiJd of lower electrophoretic mobility was the predom- 
inant form in the melanosomal nd microsomal fi'ac- 
tions. However, upon theophylline treatment, a form of 
slightly higher eleetrt~phoretic mobility (shown with ar- 
rows in Fig. 2) became increasingly evident, accounting 
for approximately 50% of the total stain in the melano- 
somal fraction after 48 h. This higher-mobility form 
was, however, the minority activity band in control 
cells, especially in the microsomal fraction. Therefore, 
SDS-PAGE showed a different degree of induction for 
two active forms of tyroslnase. 
It has recently been shown that two different genes 
mapping to the brown (b) and albino (c) loci in mice 
might encode for active tyrosinase molecules [16]. These 
proteins display extensive sequence similarity and 
should therefore share antigenic determinants. In the 
light of the results herein presented, it can be proposed 
Table II 
Tyrosine hydroxylase activity of mixtures of control and theophylline 
treated mclanosomal fractions 
Sample #U % Activity 
respect 
theoretical stun 
Exp, 1 
Control 9.05 
Theophylline 18,8 j 27.85 
Control + theophylline 24.8 89 
Control + theophylline +
0.5% SDS 26.1 94 
Exp. 2 
Control 5.7 "1. 15,6 
Theophyll]ne 9,9 1 
Control + theophylline 18,4 118 
Control + theophylline +
0,5% SDS 17,5 I 12 
Control and theophylline-treated (1 mM, 48 h) B16 cells were ~rown 
to semiconfluence, harvested, fractionated and the mel~nosomal fr.',c- 
tions purified as described in Materials and Methods. The samples 
were mixed if necessary and incubated at room temperature for 30 
rain, prior to the addition of substrates for tyrosin¢ hydroxylase activ- 
ity measurements. 
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Table III 
Activation of the dope oxidas¢ and tyrosine hydroxylase activities of tyrosinase in the mierosomal nd melanosomal fractions of BI6 mouse 
melanoma cells treated with theophylline 
Control Theophylline 
Microsomes Melanosomes Microsomes Melanosomes 
Tyrosine hydroxylase ~U/10" cells) 1,1 ± 0,15 
Dopa oxidase (mU/10 ~ cells) 0,12 +_ 9.02 
Ratio ~U/mU) 9,2 
6.0 + 1.0 16.7 + 0.8 60.5 ± 5.5 
0,68 + 0.11 0.75 __+ 0.05 2.7 ± 0.3 
8,8 22.3 22.4 
Control and theophylline treated (1 rnM, 48 h) melanoma cells were ~rown to semiconfluenee in 75.cm" flasks, harvested, counted and fractionated. 
Mierosomes and melanosomes were purified as described in Materials and Methods. The results are the mean _ S,E.M. for five independent 
experiments carried oat in duplicate. 
that the activation of tyrosinase mediated by ctMSH 
might affect to different extents the biosynthesis of both 
isoenzymes. At least in BI6 cells, the resting cells appear 
to contain predominantly a form of lower tyrosine hy- 
droxylase and higher dopa oxidase specific activity, es- 
pecially in the microsomal fraction, consistent with a 
basal situation where the rate of the melanization path- 
way is kept low. Upon ~MSH stimulation, there is a 
larger increase in the activity of a protein with higher 
tyrosine hydroxylase specific activity, thus resulting in 
a larger stimulation of the rate-limiting step of the path- 
way. Such a situation would simulate both an apparent 
activation of pre-existing tyrosinase as well as new syn- 
thesis of enzyme if the specific activity of tyrosinase is 
determined by measuring the amount of enzyme by 
means of immunologic techniques with a polyclonal 
antibody, which can be predicted to recognize both 
forms of the enzyme [5]. Conversely, if the amount of 
enzyme is determined with a monoclonal antibody di- 
rected against the form present in higher amounts under 
basal conditions, little increase in the amount of enzyme 
will be observed, and the large increase in tyrosine hy- 
droxylase activity due to the accumulation of a different 
isoenzyme not recognized by the antibody could be rea- 
sonably assigned to the activation of a preexisting pool 
of the enzyme [6]. Finally, if the specific activity is meas- 
ured under conditions where the initial situation is such 
that both enzyme forms are already present in compara- 
ble amounts, for example after a previous aMSH stim- 
ulation, or if the antibody employed to determine ty- 
rosinase amounts is mainly directed against he higher 
specific activity protein, the preferent stimulation of this 
form might lead to an interpretation of the results in 
terms of an aMSH induction without any activation of  
the enzyme [3,4]. In any case, a variety of experiments 
performed with specific antibodies have shown that 
czMSH treatment of melanocytes results in little differ- 
ences in the patterns of sylathesis of both tyrosinases, 
which were increased no more than about two-fold by 
the hormone [16]. Therefore, the induction of tyrosinase 
activity cannot be accounted for merely on the basis of 
increases in the synthesis of the isoenzymes. Other 
mechanisms such as hormone-mediated alterations in 
post-translational processing or routing to the melano- 
some might also contribute to the observed ifferences 
in isoenzyme distribution. An interesting possibility 
which is currently under study in our laboratory would 
be a differential stabilization of the isoenzymes, whose 
half-life "in vivo' is relatively short as result of active 
degradation [6]. 
In summary, the results here presented clearly point 
out the existence of two different forms of tyrosinase, 
as proposed by Hearing and co-workers [15,16]. These 
isoenzymes would have distinct catalytic properties, and 
different responses to 0~MSH. These findings provide a 
reasonable xplanation for the conflicting data on the 
stimulation by czMSH of tyrosinase in mammalian 
melanocytes. 
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